OTC : IBXNF

IBEX Technologies Inc.

$1 USD

-$0.07 (-6.54%)

Volume
375
Average Volume
2.05K
Market Capitalization
$25.27M
P/E Ratio
9.06
Dividend Yield
0.00%
Price Target
Year High
$1.10
Year Low
$0.56
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.69
Company Overview

OTC

Paul Baehr

Biotechnology

Healthcare

IBXNF

N/A

CA

USD

https://www.ibex.ca

N/A

N/A

N/A

Liquidity Metrics

0.12

5.69

5.59

4.75

0.00

Sales & Valuation

$7.49M

4.74

2.64

28.66

0.05

Profitability

$0.16

$3.89M

51.97%

26.93%

33.34%

23.13%

P/E Metrics

9.06

0.04

0.04

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

5.52

6/9

$8.82M

$17.23M

$3M

$2.75M

Key Metrics (TTM)

$28.63M

3.82

18.53

5.69

33.34%

-9.71%

10.84%

3.49%

$1.39

-160 days

Company Executives
Name Title
Belinda Franco Chief Financial Officer, Vice President of Finance & Administration and Secretary
Mahendra Kumar Pallapothu Vice President of Operations
Paul Baehr President, Chief Executive Officer & Chairman
Poll Results

No votes yet today — be the first to share your view!

About IBEX Technologies Inc. (OTC:IBXNF) Stock

Operating internationally, with key markets spanning Canada, the United States, Germany, and the United Kingdom, IBEX Technologies Inc. focuses on the development and sale of enzymes for various biomedical purposes. Its extensive product catalog includes a range of recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, alongside Chondroitinase AC and B. The company also provides sophisticated research tools, including collagen ELISAs designed to assess the formation and breakdown of connective tissue components, as well as collagen antibodies and a liquid diamine oxidase product. Furthermore, IBEX develops and commercializes various assays specifically tailored for research into osteoarthritis. Beyond its product lines, IBEX offers specialized services like lyophilization ... for creating disposable medical device parts, custom fermentation, and contract manufacturing. The firm caters to a broad clientele, encompassing medical device producers, quality control laboratories, manufacturers of low molecular weight heparin, and academic research institutions. IBEX Technologies Inc. was founded in 1972 and maintains its headquarters in Montreal, Canada.

IBEX Limited Announces $20 Million Share Repurchase Program

2026-05-13 09:00:00

WASHINGTON, May 13, 2026 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced that its Board of Directors has authorized a share repurchase program, under which the Company may repurchase up to $20 million of its common stock during the next 12 months (the “Share Repurchase Program”). “Our new repurchase program reflects our confidence in the strength of our business, financial position, and growth trajectory,” said Bob Dechant, ibex CEO.

IBEX Limited (IBEX) Q3 2026 Earnings Call Transcript

2026-05-06 22:21:18

IBEX Limited (IBEX) Q3 2026 Earnings Call Transcript

IBEX Limited to Announce Third Quarter 2026 Financial Results on May 6, 2026

2026-04-22 16:15:00

WASHINGTON, April 22, 2026 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced it will report third quarter 2026 financial results after the market close on Wednesday, May 6, 2026. Management will host a conference call and webcast to discuss the Company's financial results, recent developments, and business outlook at 4:30 p.m. ET.

Frequently Asked Questions

What is the current IBEX Technologies Inc. (IBXNF) stock price?

IBEX Technologies Inc.(OTC:IBXNF) stock price is $1 in the last trading session. During the trading session, IBXNF stock reached the peak price of $1.1 while $0.56 was the lowest point it dropped to. The percentage change in IBXNF stock occurred in the recent session was --6.54% while the dollar amount for the price change in IBXNF stock was -$0.07.

IBXNF's industry and sector of operation?

The OTC listed IBXNF is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of IBXNF?

Belinda Franco | Chief Financial Officer, Vice President of Finance & Administration and Secretary
Mahendra Kumar Pallapothu | Vice President of Operations
Paul Baehr | President, Chief Executive Officer & Chairman
|
|

How many employees does IBXNF have?

Number of IBXNF employees currently stands at None. IBXNF operates from 5485 Rue Pare, Montreal, QC H4P 1P7, CA.

Link for IBXNF official website?

Official Website of IBXNF is: https://www.ibex.ca

How do I contact IBXNF?

IBXNF could be contacted at phone #None and can also be accessed through its website. IBXNF operates from 5485 Rue Pare, Montreal, QC H4P 1P7, CA.

How many shares of IBXNF are traded daily?

The average number of IBXNF shares traded daily for last 3 months was 2.05K.

What is the market cap of IBXNF currently?

The market value of IBXNF currently stands at $25.27M with its latest stock price at $1